Judith S Hochman

Summary

Affiliation: New York University
Country: USA

Publications

  1. ncbi Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction
    Judith S Hochman
    Cardiovascular Clinical Research Center, New York University School of Medicine, New York 10016, USA
    JAMA 295:2511-5. 2006
  2. ncbi Design and methodology of the Occluded Artery Trial (OAT)
    Judith S Hochman
    Am Heart J 150:627-42. 2005
  3. ncbi Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm
    Judith S Hochman
    Division of Cardiology, New York University School of Medicine, 550 First Ave, OBV-A632, New York, NY 10016-9196, USA
    Circulation 107:2998-3002. 2003
  4. ncbi Outcome after surgery and percutaneous intervention for cardiogenic shock and left main disease
    Michael S Lee
    Division of Cardiology, University of California, Los Angeles Medical Center, Los Angeles, CA 90095 171715, USA
    Ann Thorac Surg 86:29-34. 2008
  5. ncbi Relationship of female sex to outcomes after myocardial infarction with persistent total occlusion of the infarct artery: analysis of the Occluded Artery Trial (OAT)
    Harmony R Reynolds
    Cardiovascular Clinical Research Center, New York University School of Medicine, New York, NY, USA
    Am Heart J 163:462-9. 2012
  6. ncbi Impact of female sex on death and bleeding after fibrinolytic treatment of myocardial infarction in GUSTO V
    Harmony R Reynolds
    Cardiovascular Clinical Research Center, New York University School of Medicine, New York, USA
    Arch Intern Med 167:2054-60. 2007
  7. ncbi Comparison of late results of percutaneous coronary intervention among stable patients ≤65 versus >65 years of age with an occluded infarct related artery (from the Occluded Artery Trial)
    Adam H Skolnick
    Leon H Charney Division of Cardiology, NYU Medical Center, New York, USA
    Am J Cardiol 109:614-9. 2012
  8. ncbi Echocardiographic and angiographic correlations in patients with cardiogenic shock secondary to acute myocardial infarction
    M Joshua Berkowitz
    Cardiovascular Clinical Research Center, New York University School of Medicine, New York, New York, USA
    Am J Cardiol 98:1004-8. 2006
  9. ncbi Long-term effects of percutaneous coronary intervention of the totally occluded infarct-related artery in the subacute phase after myocardial infarction
    Judith S Hochman
    Cardiovascular Clinical Research Center, Leon Charney Division of Cardiology, New York University School of Medicine, 530 First Avenue, New York, NY 10016, USA
    Circulation 124:2320-8. 2011
  10. ncbi Sex and race are associated with the absence of epicardial coronary artery obstructive disease at angiography in patients with acute coronary syndromes
    Neel P Chokshi
    Department of Medicine, Leon H Charney Division of Cardiology, New York University School of Medicine, New York, New York, USA
    Clin Cardiol 33:495-501. 2010

Research Grants

  1. Occluded Artery Trial: Long Term Follow-Up
    Judith Hochman; Fiscal Year: 2007

Detail Information

Publications81

  1. ncbi Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction
    Judith S Hochman
    Cardiovascular Clinical Research Center, New York University School of Medicine, New York 10016, USA
    JAMA 295:2511-5. 2006
    ....
  2. ncbi Design and methodology of the Occluded Artery Trial (OAT)
    Judith S Hochman
    Am Heart J 150:627-42. 2005
    ..If not, this strategy should be avoided in this large subgroup of post-MI patients...
  3. ncbi Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm
    Judith S Hochman
    Division of Cardiology, New York University School of Medicine, 550 First Ave, OBV-A632, New York, NY 10016-9196, USA
    Circulation 107:2998-3002. 2003
  4. ncbi Outcome after surgery and percutaneous intervention for cardiogenic shock and left main disease
    Michael S Lee
    Division of Cardiology, University of California, Los Angeles Medical Center, Los Angeles, CA 90095 171715, USA
    Ann Thorac Surg 86:29-34. 2008
    ..The ideal revascularization strategy (bypass surgery versus percutaneous coronary intervention [PCI]) for patients with cardiogenic shock in the setting of left main coronary artery disease is unknown...
  5. ncbi Relationship of female sex to outcomes after myocardial infarction with persistent total occlusion of the infarct artery: analysis of the Occluded Artery Trial (OAT)
    Harmony R Reynolds
    Cardiovascular Clinical Research Center, New York University School of Medicine, New York, NY, USA
    Am Heart J 163:462-9. 2012
    ....
  6. ncbi Impact of female sex on death and bleeding after fibrinolytic treatment of myocardial infarction in GUSTO V
    Harmony R Reynolds
    Cardiovascular Clinical Research Center, New York University School of Medicine, New York, USA
    Arch Intern Med 167:2054-60. 2007
    ..Use of diagnostic and therapeutic modalities may also differ. There is controversy regarding whether female sex is an independent risk factor for death and/or bleeding...
  7. ncbi Comparison of late results of percutaneous coronary intervention among stable patients ≤65 versus >65 years of age with an occluded infarct related artery (from the Occluded Artery Trial)
    Adam H Skolnick
    Leon H Charney Division of Cardiology, NYU Medical Center, New York, USA
    Am J Cardiol 109:614-9. 2012
    ..PCI reduces angina to a similar degree in the young and old. In conclusion, there is no indication for routine PCI to open a persistently occluded infarct-related artery in stable patients after myocardial infarction, regardless of age...
  8. ncbi Echocardiographic and angiographic correlations in patients with cardiogenic shock secondary to acute myocardial infarction
    M Joshua Berkowitz
    Cardiovascular Clinical Research Center, New York University School of Medicine, New York, New York, USA
    Am J Cardiol 98:1004-8. 2006
    ..Echocardiography and angiography are valuable and result in similar estimated ejection fractions in a large cohort, but there is wide variation between the techniques in patients...
  9. ncbi Long-term effects of percutaneous coronary intervention of the totally occluded infarct-related artery in the subacute phase after myocardial infarction
    Judith S Hochman
    Cardiovascular Clinical Research Center, Leon Charney Division of Cardiology, New York University School of Medicine, 530 First Avenue, New York, NY 10016, USA
    Circulation 124:2320-8. 2011
    ..9-year mean follow-up. Follow-up was extended to determine whether late trends would favor either treatment group...
  10. ncbi Sex and race are associated with the absence of epicardial coronary artery obstructive disease at angiography in patients with acute coronary syndromes
    Neel P Chokshi
    Department of Medicine, Leon H Charney Division of Cardiology, New York University School of Medicine, New York, New York, USA
    Clin Cardiol 33:495-501. 2010
    ..We examined the frequency of this finding and its relationship to race and sex...
  11. ncbi Causes of death and re-hospitalization in cardiogenic shock
    Raban V Jeger
    Cardiovascular Clinical Research Center, New York University School of Medicine, 530 First Avenue, New York, NY 10016, USA
    Acute Card Care 9:25-33. 2007
    ..In cardiogenic shock, causes of death usually are cardiac. However, a systemic inflammatory response syndrome may influence outcome...
  12. ncbi Interhospital transfer for early revascularization in patients with ST-elevation myocardial infarction complicated by cardiogenic shock--a report from the SHould we revascularize Occluded Coronaries for cardiogenic shocK? (SHOCK) trial and registry
    Raban V Jeger
    Cardiovascular Clinical Research Center, New York University School of Medicine, New York, NY, USA
    Am Heart J 152:686-92. 2006
    ..Patients admitted to hospitals without revascularization capability have high mortality rates and are not often transferred for ERV...
  13. ncbi Hemodynamic parameters are prognostically important in cardiogenic shock but similar following early revascularization or initial medical stabilization: a report from the SHOCK Trial
    Raban V Jeger
    Cardiovascular Clinical Research Center, New York University School of Medicine, New York, NY, USA
    Chest 132:1794-803. 2007
    ..In cardiogenic shock (CS), conclusive data on serial hemodynamic measurements for treatment guidance and prognosis are lacking...
  14. ncbi Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early
    Erika R Gehrie
    New York University School of Medicine, New York, NY, USA
    Am Heart J 158:688-94. 2009
    ..Sex-specific characteristics and outcomes of patients without obstructive coronary artery disease (CAD) have not been described previously...
  15. ncbi Effect of late revascularization of a totally occluded coronary artery after myocardial infarction on mortality rates in patients with renal impairment
    Ramin S Hastings
    Cardiovascular Clinical Research Center, Division of Cardiology, New York University School of Medicine, New York, New York, USA
    Am J Cardiol 110:954-60. 2012
    ..Despite this increased risk, the lack of benefit from percutaneous coronary intervention in the overall trial was also seen in patients with renal dysfunction and persistent occlusion of the infarct artery in the subacute phase after MI...
  16. ncbi Coronary intervention for persistent occlusion after myocardial infarction
    Judith S Hochman
    Cardiovascular Clinical Research Center, Leon Charney Division of Cardiology, New York University School of Medicine, New York 10016, USA
    N Engl J Med 355:2395-407. 2006
    ..ClinicalTrials.gov number, NCT00004562 [ClinicalTrials.gov].)...
  17. ncbi An early revascularization strategy is associated with a survival benefit for diabetic patients in cardiogenic shock after acute myocardial infarction
    Michael E Farkouh
    Cardiovascular Institute, Mount Sinai School of Medicine, Mount Sinai Medical Center, New York, New York 10029, USA
    Clin Cardiol 29:204-10. 2006
    ..The role of diabetes mellitus (DM) in cardiogenic shock (CS) complicating an acute myocardial infarction (AMI) is not well understood. Previous studies have reported an in-hospital mortality rate for patients with DM and CS of about 60%...
  18. ncbi Early revascularization is beneficial across all ages and a wide spectrum of cardiogenic shock severity: A pooled analysis of trials
    Raban V Jeger
    Cardiovascular Clinical Research Center, New York University School of Medicine, New York, NY, USA
    Acute Card Care 13:14-20. 2011
    ..A pooled analysis in cardiogenic shock due to acute coronary syndromes is desirable to assess the effect of early revascularization (ERV) across all ages and a wide spectrum of disease severity...
  19. ncbi Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease
    Harmony R Reynolds
    Cardiovascular Clinical Research Center, 530 First Ave SKI 9R, New York, NY 10016, USA
    Circulation 124:1414-25. 2011
    ..We sought to determine the mechanism(s) of myocardial infarction in this setting using multiple imaging techniques...
  20. ncbi Emergency revascularization in patients with cardiogenic shock on admission: a report from the SHOCK trial and registry
    Raban V Jeger
    Cardiovascular Clinical Research Center, New York University School of Medicine, 530 First Avenue, HCC 1173, New York, NY 10016, USA
    Eur Heart J 27:664-70. 2006
    ..To determine clinical correlates and optimal treatment strategy in patients with cardiogenic shock (CS) on admission...
  21. ncbi Restrictive physiology in cardiogenic shock: observations from echocardiography
    Harmony R Reynolds
    Department of Medicine, New York University School of Medicine, New York, NY, USA
    Am Heart J 151:890.e9-15. 2006
    ..We hypothesized that restrictive physiology plays a role in cardiogenic shock (CS)...
  22. ncbi Thrombolysis and adjunctive therapy in acute myocardial infarction: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
    Venu Menon
    Division of Cardiology, University of North Carolina at Chapel Hill, 27599, USA
    Chest 126:549S-575S. 2004
    ....
  23. ncbi Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry
    Rupert Fincke
    New York Presbyterian Hospital-Weill Cornell Medical Center, New York, New York, USA
    J Am Coll Cardiol 44:340-8. 2004
    ..032). CONCLUSIONS: Cardiac power is the strongest independent hemodynamic correlate of in-hospital mortality in patients with cardiogenic shock. Increasing age and female gender are independently associated with lower cardiac power...
  24. ncbi Rapid complete reversal of systemic hypoperfusion after intra-aortic balloon pump counterpulsation and survival in cardiogenic shock complicating an acute myocardial infarction
    Krishnan Ramanathan
    New York University School of Medicine, NY 10016, USA
    Am Heart J 162:268-75. 2011
    ..Intra-aortic balloon counterpulsation (IABC) provides hemodynamic support and facilitates coronary angiography and revascularization in CS patients...
  25. ncbi Impact of the New York State Cardiac Surgery and Percutaneous Coronary Intervention Reporting System on the management of patients with acute myocardial infarction complicated by cardiogenic shock
    Renato A Apolito
    Cardiovascular Clinical Research Center, The Leon H Charney Department of Cardiology, New York University School of Medicine, New York, NY 10016, USA
    Am Heart J 155:267-73. 2008
    ....
  26. ncbi Women have less severe and extensive coronary atherosclerosis in fatal cases of ischemic heart disease: an autopsy study
    Nathaniel R Smilowitz
    Cardiovascular Clinical Research Center, New York University School of Medicine, NY 10016, USA
    Am Heart J 161:681-8. 2011
    ..The study aims to evaluate sex differences in extent and severity of coronary artery disease (CAD) and myocardial findings at autopsy among young people with fatal ischemic heart disease (IHD)...
  27. ncbi Cardiovascular disease in young women: a population at risk
    Rebecca D Levit
    Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
    Cardiol Rev 19:60-5. 2011
    ....
  28. ncbi Microbiological profile of septic complication in patients with cardiogenic shock following acute myocardial infarction (from the SHOCK study)
    Shun Kohsaka
    Division of Cardiology, Columbia University, College of Physicians and Surgeons, New York, New York, USA
    Am J Cardiol 99:802-4. 2007
    ..026). In conclusion, clinical sepsis is common after cardiogenic shock complicating acute myocardial infarction, particularly in patients who received prolonged IABP support or had multiple central catheters...
  29. ncbi Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock
    Anvar Babaev
    Cardiovascular Clinical Research Center, New York University School of Medicine, New York, NY 10016, USA
    JAMA 294:448-54. 2005
    ..The American College of Cardiology and American Heart Association guidelines had no detectable temporal impact on revascularization rates. These findings support the need for increased adherence to these guidelines...
  30. ncbi Relation between hospital intra-aortic balloon counterpulsation volume and mortality in acute myocardial infarction complicated by cardiogenic shock
    Edmond W Chen
    Division of Cardiology, Kaiser Permanente Medical Group, Inc, Richmond, CA 94801-3195, USA
    Circulation 108:951-7. 2003
    ..CONCLUSIONS: Among the myocardial infarction patients with cardiogenic shock who underwent IABP placement, mortality rate was significantly lower at high-IABP volume hospitals compared with low-IABP volume hospitals...
  31. ncbi Cardiogenic shock: current concepts and improving outcomes
    Harmony R Reynolds
    Leon H. Charney Division of Cardiology, Cardiovascular Clinical Research Center, New York University School of Medicine, 530 First Ave, New York, NY 10016, USA
    Circulation 117:686-97. 2008
  32. ncbi Lack of benefit from percutaneous intervention of persistently occluded infarct arteries after the acute phase of myocardial infarction is time independent: insights from Occluded Artery Trial
    Venu Menon
    Division of Cardiology, F 15, 9500 Euclid Avenue, Cleveland Clinic, Cleveland, OH 4419, USA
    Eur Heart J 30:183-91. 2009
    ..We evaluated the potential for selective benefit with PCI over MED for patients enrolled early in OAT...
  33. ncbi Sex differences in mortality following acute coronary syndromes
    Jeffrey S Berger
    Department of Medicine, New York University School of Medicine, 530 First Ave, Skirball 9R, New York, NY 10016, USA
    JAMA 302:874-82. 2009
    ..Conflicting information exists about whether sex differences modulate short-term mortality following acute coronary syndromes (ACS)...
  34. ncbi Heart Failure in Post-MI Patients With Persistent IRA Occlusion: Prevalence, Risk Factors, and the Long-Term Effect of PCI in the Occluded Artery Trial (OAT)
    Rahul R Jhaveri
    Cardiovascular Clinical Research Center, Leon Charney Division of Cardiology, New York University School of Medicine, New York, NY
    J Card Fail 18:813-21. 2012
    ..The incidence and predictors of heart failure (HF) after myocardial infarction (MI) with modern post-MI treatment have not been well characterized...
  35. ncbi Long-term outcomes in non-diabetic patients with metabolic syndrome undergoing revascularization for multi-vessel coronary artery disease
    Leonid Yatskar
    New York University School of Medicine, New York, NY, United States
    Atherosclerosis 198:389-95. 2008
    ..We studied the impact of MS on long-term outcomes in non-diabetic patients (NDM) with MV-CAD undergoing coronary revascularization in the Bypass Angioplasty Revascularization Investigation (BARI) trial and registry...
  36. ncbi South Asians and risk of cardiovascular disease: current insights and trends
    Sandeep S Mangalmurti
    Department of Medicine, New York University, New York, USA
    Ethn Dis 20:474-8. 2010
    ..Current guidelines for primary and secondary prevention have not reflected our growing insight into the unique characteristics of the South Asian population, and may need to evolve to reflect our knowledge...
  37. ncbi Management of cardiogenic shock complicating acute myocardial infarction
    Venu Menon
    Division of Cardiology, University of North Carolina, Chapel Hill, North Carolina, USA
    Heart 88:531-7. 2002
  38. ncbi Benefits of direct angioplasty for women and men with acute myocardial infarction: results of the Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes Angioplasty (GUSTO II-B) Angioplasty Substudy
    Jacqueline E Tamis-Holland
    Division of Cardiology, St Luke s Roosevelt Hospital Center and Columbia University College of Physicians and Surgeons, New York, NY 10025, USA
    Am Heart J 147:133-9. 2004
    ..Direct angioplasty (PTCA) and thrombolytic therapy are the chief therapies for treating an ST-segment elevation myocardial infarction (MI)...
  39. ncbi Establishing a new target range for unfractionated heparin for acute coronary syndromes
    Michael S Lee
    St. Luke's-Roosevelt Hospital Center, Division of Cardiology, College of Physicians and Surgeons, Columbia University, 1111 Amsterdam Avenue, New York City, NY 10025, USA
    J Thromb Thrombolysis 17:121-6. 2004
    ..Institutional standardization of the aPTT is necessary to ensure optimal patient care when changing thromboplastin reagents...
  40. ncbi Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary artery occlusion to achieve long-term patency and improve ventricular function: the Total Occlusion Study of Canada (TOSCA)-2 trial
    Vladimir Dzavik
    University Health Network, University of Toronto, Toronto, Ontario, Canada
    Circulation 114:2449-57. 2006
    ....
  41. ncbi Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial
    John H Alexander
    Duke University, Durham, NC, USA
    JAMA 297:1657-66. 2007
    ..Preliminary, single-center studies suggested a beneficial effect of NOS inhibition on hemodynamics, renal function, and survival in patients with cardiogenic shock...
  42. ncbi Influence of thrombolytic therapy, with or without intra-aortic balloon counterpulsation, on 12-month survival in the SHOCK trial
    John K French
    Department of Cardiology, Green Lane Hospital, Auckland, New Zealand
    Am Heart J 146:804-10. 2003
    ..We examined the relation between TT (with and without IABP) and 12-month survival in the SHould We Emergently Revascularize Occluded Coronaries for Cardiogenic ShocK (SHOCK) Trial...
  43. ncbi Metabolic profiling of arginine and nitric oxide pathways predicts hemodynamic abnormalities and mortality in patients with cardiogenic shock after acute myocardial infarction
    Stephen J Nicholls
    Department of Cardiovascular Medicine and Center for Cardiovascular Diagnostics and Prevention, Cleveland Clinic Foundation, 9500 Euclid Ave, NE 10, Cleveland, OH 44195, USA
    Circulation 116:2315-24. 2007
    ..It is unclear whether abnormalities of arginine and nitric oxide metabolism are related to hemodynamic dysfunction and mortality in patients with cardiogenic shock (CS) after acute myocardial infarction...
  44. ncbi Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging study
    Vladimir Dzavik
    University Health Network, Toronto General Hospital, 6 246, 200 Elizabeth Street, Toronto M5G 2C4, Ontario, Canada
    Eur Heart J 28:1109-16. 2007
    ..We assessed preliminary efficacy and safety of four doses of l-n-monomethyl-arginine (l-NMMA), a non-selective NOS inhibitor, in patients with AMI complicated by CS despite an open infarct-related artery...
  45. ncbi ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999
    Elliott M Antman
    Circulation 110:588-636. 2004
  46. ncbi ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999
    Elliott M Antman
    Can J Cardiol 20:977-1025. 2004
  47. ncbi Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock
    Shun Kohsaka
    Department of Cardiology, Texas Heart Institute at St Luke's Episcopal Hospital and Baylor College of Medicine, Houston, USA
    Arch Intern Med 165:1643-50. 2005
    ....
  48. ncbi ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999
    Elliott M Antman
    J Am Coll Cardiol 44:671-719. 2004
  49. ncbi Acute administration of angiotensin converting enzyme inhibitors in thrombolysed myocardial infarction patients is associated with a decreased incidence of heart failure, but an increased re-infarction risk
    Adriaan A Voors
    Department of Cardiology, University Hospital Groningen, The Netherlands
    Cardiovasc Drugs Ther 19:119-24. 2005
    ..The aim of the present study was to evaluate the effects of acute ACE-inhibitor treatment...
  50. ncbi Functional status and quality of life after emergency revascularization for cardiogenic shock complicating acute myocardial infarction
    Lynn A Sleeper
    New England Research Institutes, Watertown, Massachusetts 02472, USA
    J Am Coll Cardiol 46:266-73. 2005
    ....
  51. ncbi Outcome of patients aged >or=75 years in the SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK (SHOCK) trial: do elderly patients with acute myocardial infarction complicated by cardiogenic shock respond differently to emergent r
    Vladimir Dzavik
    Interventional Cardiology Program, University Health Network, and University of Toronto, Toronto, Ontario, Canada
    Am Heart J 149:1128-34. 2005
    ..We sought to determine the reason for this finding by examining the baseline characteristics and outcomes of the 2 treatment groups by age...
  52. ncbi Cardiogenic shock: predictors of outcome based on right and left ventricular size and function at presentation
    Lisa A Mendes
    Boston Medical Center, Massachusetts, USA
    Coron Artery Dis 16:209-15. 2005
    ....
  53. ncbi Electrocardiographic findings in cardiogenic shock, risk prediction, and the effects of emergency revascularization: results from the SHOCK trial
    Harvey D White
    Cardiovascular Research Unit, Green Lane Hospital, Auckland, New Zealand
    Am Heart J 148:810-7. 2004
    ....
  54. ncbi Prognostic usefulness of white blood cell count and temperature in acute myocardial infarction (from the CARDINAL Trial)
    Manesh R Patel
    Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA
    Am J Cardiol 95:614-8. 2005
    ..Baseline and serial measurements of WBC counts and temperature were correlated with infarct size and clinical outcome...
  55. ncbi Cardiogenic shock caused by right ventricular infarction: a report from the SHOCK registry
    Alice K Jacobs
    Department of Medicine, Boston Medical Center, Massachusetts 02118, USA
    J Am Coll Cardiol 41:1273-9. 2003
    ..The purpose of this study was to determine the characteristics and outcomes of patients with acute myocardial infarction (MI) complicated by cardiogenic shock due to predominant right ventricular (RV) infarction...
  56. ncbi Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial
    John G Webb
    St Paul s Hospital, Vancouver, Canada
    J Am Coll Cardiol 42:1380-6. 2003
    ..We examined the clinical, angiographic, and procedural characteristics determining survival after percutaneous coronary intervention (PCI) for cardiogenic shock...
  57. ncbi Correlates of one-year survival inpatients with cardiogenic shock complicating acute myocardial infarction: angiographic findings from the SHOCK trial
    Timothy A Sanborn
    Evanston Northwestern Healthcare, Evanston, Illinois 60201, USA
    J Am Coll Cardiol 42:1373-9. 2003
    ....
  58. ncbi Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial
    A Michael Lincoff
    Department of Cardiovascular Medicine, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195, USA
    JAMA 288:2130-5. 2002
    ..Rates of nonfatal ischemic complications were significantly diminished...
  59. ncbi Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK)
    Harvey D White
    Green Lane Cardiovascular Service, Auckland City Hospital, Auckland 1030, New Zealand
    Circulation 112:1992-2001. 2005
    ..The objective of this analysis was to compare the effects of PCI and CABG on 30-day and 1-year survival in the SHOCK trial...
  60. ncbi Racial and ethnic differences in the treatment and outcome of cardiogenic shock following acute myocardial infarction
    Sebastian T Palmeri
    UMDNJ Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA
    Am J Cardiol 96:1042-9. 2005
    ..Therefore, early revascularization should be strongly considered for all patients, independent of race/ethnicity, who develop cardiogenic shock after acute myocardial infarction...
  61. ncbi Echocardiographic predictors of survival and response to early revascularization in cardiogenic shock
    Michael H Picard
    Massachusetts General Hospital and Harvard Medical School, Boston, Mass 02114, USA
    Circulation 107:279-84. 2003
    ....
  62. ncbi Concerning the mechanism of pexelizumab's benefit in acute myocardial infarction
    Paul W Armstrong
    The University of Alberta, Edmonton, Alberta, Canada
    Am Heart J 151:787-90. 2006
    ....
  63. ncbi Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative
    Deepak L Bhatt
    Cleveland Clinic Foundation, Department of Cardiovascular Medicine Desk F25, Cleveland, Ohio 44195, USA
    JAMA 292:2096-104. 2004
    ..This strategy appears to be reserved for patients without significant comorbidities and those cared for by cardiologists and is associated with a lower risk of in-hospital mortality...
  64. ncbi Clinical and angiographic characteristics of patients with combined anterior and inferior ST-segment elevation on the initial electrocardiogram during acute myocardial infarction
    Saihari Sadanandan
    University of Oklahoma Health Sciences Center, Oklahoma City, Okla 73104, USA
    Am Heart J 146:653-61. 2003
    ....
  65. ncbi Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial
    Christopher B Granger
    Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA
    Circulation 108:1184-90. 2003
    ....
  66. ncbi Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial
    James J Ferguson
    JAMA 292:45-54. 2004
    ..Enoxaparin is a safe and effective alternative to unfractionated heparin and the advantages of convenience should be balanced with the modest excess of major bleeding...
  67. ncbi Acute ST-segment elevation myocardial infarction and prior stroke: an analysis from the Magnesium in Coronaries (MAGIC) trial
    Howard A Cooper
    Washington Hospital Center, Washington, DC 20010, USA
    Am Heart J 148:1012-9. 2004
    ..However, the impact of prior stroke on prognosis has not been rigorously examined in the reperfusion era...
  68. ncbi Prognostic implication of activated partial thromboplastin time after reteplase or half-dose reteplase plus abciximab: results from the GUSTO-V trial
    Brahmajee K Nallamothu
    University of Michigan Medical Center, Ann Arbor, MI, USA
    Eur Heart J 26:1506-12. 2005
    ..CONCLUSION: Peak aPTT levels <50 s and >70 s are associated with worse clinical outcomes in the modern era of fibrinolytic therapy; these relationships are different in patients receiving standard reteplase vs. combination therapy...
  69. ncbi N-terminal pro-brain natriuretic peptide and the timing, extent and mortality in ST elevation myocardial infarction
    Justin A Ezekowitz
    University of Alberta, Edmonton, Canada
    Can J Cardiol 22:393-7. 2006
    ..NT-proBNP at baseline, 24 h and 72 h after presentation with acute STEMI, is an independent predictor of a poor outcome and adds clinically useful prognostic information...
  70. ncbi Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study
    Abhinav Goyal
    Duke Clinical Research Institute and Duke University Medical Center, PO Box 17969, Durham, NC 27715, USA
    Eur Heart J 27:1289-97. 2006
    ..We evaluated the prognostic significance of baseline glucose and the change in glucose in the first 24 h following AMI...
  71. ncbi Does preventive PCI work?
    Judith S Hochman
    N Engl J Med 356:1572-4. 2007
  72. ncbi The relationship between baseline risk and mortality in ST-elevation acute myocardial infarction treated with pharmacological reperfusion: insights from the Global Utilization of Strategies To open Occluded arteries (GUSTO) V trial
    Sorin J Brener
    Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    Am Heart J 150:89-93. 2005
    ....
  73. ncbi Heart failure with preserved left ventricular systolic function among patients with non-ST-segment elevation acute coronary syndromes
    Kyla M Bennett
    Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina
    Am J Cardiol 99:1351-6. 2007
    ..Guideline-recommended therapies and interventions are under-utilized in patients with NSTE ACS and HF, with and without preserved systolic function, compared with those without HF...
  74. ncbi Use of evidence-based medicine for acute coronary syndromes in the elderly and very elderly: insights from the Sibrafiban vs aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes trials
    Cheuk Kit Wong
    Cardiology, Dunedin School of Medicine, Otago University, Dunedin, New Zealand
    Am Heart J 154:313-21. 2007
    ..Evidence-based medications (EBM) are underused in older patients despite potentially larger absolute benefits. Little is known about factors influencing prescribing in the elderly with acute coronary syndromes...
  75. ncbi ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise th
    Jeffrey L Anderson
    Circulation 116:e148-304. 2007
  76. ncbi ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise th
    Jeffrey L Anderson
    J Am Coll Cardiol 50:e1-e157. 2007
  77. ncbi Where does the Occluded Artery Trial leave the late open artery hypothesis?
    Gervasio A Lamas
    Heart 93:1319-21. 2007
    ..Efforts should focus on establishing reperfusion earlier, including reducing the time to patient presentation...
  78. ncbi Elevated body mass index and intermediate-term clinical outcomes after acute coronary syndromes
    Eric L Eisenstein
    Duke University Medical Center and the Duke Clinical Research Institute, Durham, NC 27715, USA
    Am J Med 118:981-90. 2005
    ..We evaluated the relationship between elevated body mass index (BMI) and 30-day, 90-day, and 1-year clinical outcomes postacute coronary syndromes...
  79. ncbi The calm after the storm: long-term survival after cardiogenic shock
    Judith S Hochman
    J Am Coll Cardiol 50:1759-60. 2007
  80. ncbi 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
    Elliott M Antman
    J Am Coll Cardiol 51:210-47. 2008
  81. ncbi Challenging coronary artery revascularization paradigms
    Eric R Bates
    Am Heart J 154:1005-7. 2007

Research Grants2

  1. Occluded Artery Trial: Long Term Follow-Up
    Judith Hochman; Fiscal Year: 2007
    ....